Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
第一作者:
Björn,Reuter
第一单位:
From the Department of Neurology, Universitätsmedizin Mannheim (B.R., S.G., E.C., S.M., A.E., M.G.H., M.F.) and Computer Assisted Clinical Medicine, Medical Faculty Mannheim (P.H., L.R.S.), University of Heidelberg, Mannheim, Germany; and Nervous System Department, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.S.) bjoern.reuter@uniklinik-freiburg.de.
作者:
医学主题词
动物(Animals);脑缺血(Brain Ischemia);脑淀粉样血管病(Cerebral Amyloid Angiopathy);脑出血(Cerebral Hemorrhage);女(雌)性(Female);纤维蛋白溶解药(Fibrinolytic Agents);男(雄)性(Male);小鼠(Mice);小鼠, 转基因(Mice, Transgenic);危险因素(Risk Factors);卒中(Stroke);血栓溶解疗法(Thrombolytic Therapy);组织型纤溶酶原激活物(Tissue Plasminogen Activator)
DOI
10.1161/STROKEAHA.113.004483
PMID
25005438
发布时间
2016-11-22
- 浏览65
Stroke
2411-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



